Latest Diopsys Inc. Stories
Diopsys® NOVA ERG and VEP protocols along with tests looking at optic nerve structure can be used for evaluation of glaucoma progression Pine Brook, NJ
Findings help product development at Diopsys, Inc. Pine Brook, NJ (PRWEB) October 10, 2014 Research scientists from the University of Alabama, Birmingham
New study shows that the Diopsys NOVA-ERG acts as window to the brain Pine Brook, NJ (PRWEB) October 09, 2014 Research scientists from the University
Diopsys® NOVA-ERG provides a way to discriminate between AMD and healthy eyes. Pine Brook, NJ (PRWEB) July 01, 2014 In a controlled clinical study,
Diopsys® NOVA-VEP data shows new hope for patients with degenerative eye diseases. Pine Brook, NJ (PRWEB) May 30, 2014 Affecting an estimated 60
Clinical electrophysiology of vision is a well-regarded and researched science with over 50 years of clinical data.
The new Diopsys® Report Viewer software is a must have for doctors to view patients’ NOVA reports on their iPads. Pine Brook, NJ (PRWEB) March 26, 2014
Recent research shows VEP and ERG data may be used to help ophthalmologists and optometrists diagnose glaucoma early, leading to better patient outcomes. Diopsys, Inc.
Two events at the American Academy of Ophthalmology Meeting (AAO) highlighted the importance of visual evoked potential (VEP) and pattern electroretinography (ERG) being used in the clinical assessment
Research presented at the recent American Academy of Optometry (AAO) meeting reveals the powerful clinical utility of the Diopsys® NOVA-VEP Vision Testing System in the assessment of traumatic
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.